Marijuana is a Schedule I substance under the Controlled Substances Act, meaning that it has a high potential for abuse, is not currently accepted for medical use as a treatment in the United States, and is not safe for use under medical supervision. Cannabis is a natural product whose main psychoactive component is tetrahydrocannabinol (Δ9-THC). The cannabis plant (Cannabis sativa L). Along with tobacco, alcohol and caffeine, it is one of the most consumed drugs in the world and has been used as a drug and source of fiber since historic times.
Herbal cannabis is made up of dried leaves and flower tops. Cannabis resin is a compressed solid made from the resinous parts of the plant, and cannabis oil (hashish) is a solvent extract of cannabis. Cannabis is almost always smoked, often mixed with tobacco. Almost all the consumption of herbs, cannabis and resin is made of illicit material.
It has been stated that cannabis has some therapeutic benefit as an analgesic, and dronabinol is a drug authorized in some countries for the treatment of nausea in cancer chemotherapy. Cannabis products and Δ9-THC are under international control. For many people, this is outrageous. Obviously, marijuana isn't as dangerous as heroin.
And it's no more dangerous than Schedule 2 drugs, such as cocaine and methamphetamine. So why the hell is marijuana on calendar 1? Schedule 1 drugs have no medical value and have a high potential for abuse, while all substances in Schedule 2 to 5 have some medical value, but their classification varies according to their potential for abuse (from high to low). In general, Schedule 1 and 2 drugs have the strictest regulatory restrictions on research, supply and access, and Schedule 5 drugs have the least. But that doesn't necessarily mean that the federal government considers marijuana and heroin to be equally dangerous drugs, or that it considers marijuana to be more dangerous than methamphetamine or cocaine.The drugs in lists 1 and 2 are described as having a high potential for abuse, a vague description that does not classify drugs in the two categories as the same or different.
Instead, the big difference between Schedule 1 and 2 substances is whether the federal government believes a drug has medical value. The DEA states that Schedule 2 substances have any medical value and those in Schedule 1 do not, so the latter receive greater regulatory scrutiny, even if they are not more dangerous. Schedule 1 and 2 drugs face the most stringent regulations.Schedule 1 drugs are effectively illegal for anything unrelated to research, and Schedule 2 drugs can be used for limited medical purposes with DEA approval, such as through a prescription license. The DEA even sets strict limits on the production of list 1 and 2 drugs, although the limits vary from drug to drug.
Currently, only in one location in the U. S., a University of Mississippi farm, marijuana is allowed to grow under federal regulations, and marijuana is limited to research purposes. By comparison, several private companies produce oxycodone, a Schedule 2 substance, and use it as prescription pain relievers.A medication schedule may interfere with state laws. The status of marijuana in Schedule 1 is one of the reasons banks are reluctant to open accounts for marijuana stores and producers in Colorado and Washington, even though businesses are legal under state law.
Federal tax law also prohibits companies from deducting many expenses related to category 1 and 2 drug trafficking, which can cause the effective income tax rates of statutory state-owned companies on income to soar by up to 90 percent. The two main recreational drugs that are not included in the classification system, alcohol and tobacco, required a specific exemption in the Controlled Substances Act.Mark Kleiman, an expert in drug policy, argues that both would rank in list 1 if evaluated today since they are widely used for recreational purposes, are addictive, are harmful to health and society and are deadly. When the classification of marijuana is reviewed its status in Schedule 1 is maintained on a consistent basis due to insufficient scientific evidence of its medicinal value. However one of the reasons why there is not enough scientific evidence to change the status of marijuana in Schedule 1 could in fact be the status of the Schedule 1 drug.
The DEA restricts the amount of marijuana that can be used for research.To obtain legal supplies of marijuana for studies researchers must obtain approval for their studies by HHS FDA and DEA. While a reclassification would be a symbolic victory for legalization advocates Kleiman says it wouldn't have much practical effect. Schedule 2 substances usually require a prescription to be distributed and state-legal marijuana dispensaries and outlets do not use traditional prescriptions (they distribute recommendations for medical marijuana) so even reprogramming may not open access Cocaine and methamphetamine are on Schedule 2 and after all they're definitely not easily available legally.However the DEA hopes that its other measures will result in much more research There are exceptions such as when the drug was marketed in food before the drug was approved or before major clinical research on the drug had started or in the case of animal feed if the drug is a new drug for animals approved for use in feed and is used in accordance with approved labeling Unlike drugs approved by FDA products that have not been reviewed by FDA as part of drug approval process have not been evaluated to determine if they work what appropriate dose might be if they work how they might interact with other drugs or if they have dangerous side effects or other safety problems So what is scheduling system how does it work what would it take to reprogram medication Here's What You Need Know.A stricter schedule allows DEA more strictly limit access supply drug which can make difficult research.
Leave a Comment